Read reviews, check prices and availability, and book a same-day video visit for as low as $34
The practical takeaway: if the Wegovy pill's administration requirements feel like a barrier for you, it may be worth waiting to see how orforglipron's FDA review unfolds over the next 12 months before making a long-term treatment decision

GLP-1 receptor agonists may improve psoriatic skin disease through combined metabolic and immunomodulatory effects Observational studies show reductions in PASI scores, with improvements of approximately 40% to 80% Treatment is associated with better patient-reported quality of life Benefits extend beyond glycemic control and weight loss Agents such as semaglutide and liraglutide reduce inflammatory markers, including C-reactive protein and interleukin-6 Improvements in lipid profile and reductions in visceral fat have been reported Psoriasis improvement may correlate with reduced superficial adiposity and decreased dermal T-cell density GLP-1 receptor agonists can be safely combined with methotrexate, cyclosporine, and biologic therapies The safety profile is generally favorable, with mostly transient gastrointestinal side effects Serious adverse events such as pancreatitis and gallbladder complications are rare but require monitoring MSc

Body composition analysis (BIA) Measuring fat, muscle, and hydration for weight management
However, these effects are expected with the procedure rather than specific to the peptide